Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT01698333
Eligibility Criteria:
Inclusion Criteria:
* Subject has a clinical diagnosis of stable plaque psoriasis
Exclusion Criteria:
* Subject has spontaneously improving or rapidly deteriorating plaque psoriasis
* Subject has guttate, pustular, erythrodermic or other non-plaque forms of psoriasis
* Subject has used any phototherapy, photo-chemotherapy or systemic psoriasis therapy within 30 days prior to initiation of treatment
* Subject has used systemic corticosteroids or topical, inhaled, intranasal corticosteroids within 30 days and 14 days, respectively, prior to study screening
* Subject has had prolonged exposure to natural or artificial sources of ultraviolet radiation within 30 days prior to initiation of treatment
* Subject has used topical psoriatic therapy including tar, anthralin, retinoids, vitamin D analogs (e.g., Dovonex®) within 14 days prior to initiation of treatment
* Subject has used emollients/moisturizers on areas to be treated within one day prior to initiation of treatment
* Subject is currently using lithium or Plaquenil (hydroxychloroquine)
* Subject is currently using a beta-blocking medication (e.g., propranolol) or angiotensin converting enzyme (ACE) inhibitors (e.g., lisinopril) at a dose that has not been stabilized
* Subject is pregnant, nursing or planning a pregnancy during the study period
* Subject is currently enrolled in an investigational drug, biologic or device study
* Subject has received an investigational drug, biologic or an investigational device within 30 days prior to study start
* Subject has been previously enrolled in this study and treated with the test article
* Subject has an irregular sleep schedule or works night shifts
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01698333
Study Brief:
Protocol Section:
NCT01698333